chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.5
Sex: F
Vaccine: IPV
Symptoms: Medication error, No adverse event, Product storage error
Clinical narrative: accidentally left the refrigerator door open too long/3 separate excursions with the same vaccines. Total: low of 1.85C for 30 minutes and a high of 8.74C for 60 minutes with no reported adverse event; accidentally left the refrigerator door open too long/3 separate excursions with the same vaccines. Total: low of 1.85C for 30 minutes and a high of 8.74C for 60 minutes/administered to the patient: Yes with no reported AE; Initial information was received on 21-Jul-2023 regarding an unsolicited valid non-serious case received from a physician.  This case involves 6 months old female patient who experienced accidentally left the refrigerator door open too long/3 separate excursions with the same vaccines. total: low of 1.85c for 30 minutes and a high of 8.74c for 60 minutes with no reported adverse event and accidentally left the refrigerator door open too long/3 separate excursions with the same vaccines. total: low of 1.85c for 30 minutes and a high of 8.74c for 60 minutes/administered to the patient: yes with no reported ae after receiving ipv (VERO) [Ipol].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 07-Jun-2023, the patient received a dose of 0.5 ml of suspect ipv (VERO) (Suspension for injection) (lot V1A021M, Expiry date : 27-Feb-2024) (strength: provided as standard) via intramuscular route in unknown administration site for Immunization and developed a non-serious event of accidentally left the refrigerator door open too long/3 separate excursions with the same vaccines. total: low of 1.85c for 30 minutes and a high of 8.74c for 60 minutes with no reported adverse event (product storage error) and accidentally left the refrigerator door open too long/3 separate excursions with the same vaccines. total: low of 1.85c for 30 minutes and a high of 8.74c for 60 minutes/administered to the patient: yes with no reported ae (poor quality product administered) (latency : same day) following the administration of ipv (VERO).  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event accidentally left the refrigerator door open too long/3 separate excursions with the same vaccines. total: low of 1.85c for 30 minutes and a high of 8.74c for 60 minutes with no reported adverse event and was Unknown for the event accidentally left the refrigerator door open too long/3 separate excursions with the same vaccines. total: low of 1.85c for 30 minutes and a high of 8.74c for 60 minutes/administered to the patient: yes with no reported ae.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 6.0
Sex: F
Vaccine: IPV
Symptoms: Medication error, No adverse event, Poor quality product administered, Product storage error
Clinical narrative: IPOL were exposed to a temperature excursion/low of 1.85C for 30 minutes and a high of 8.74C for 60 minutes/ accidentally left the refrigerator door open too long/Product used:Used, with no reported adverse event; Initial information was received on 22-Jul-2023 regarding an unsolicited valid non-serious case received from a physician.  This case involves a 6 years old female patient who received poliomyelitis vaccine (inactivated) (ipv) (vero) [Ipol] which were exposed to a temperature excursion/low of 1.85c for 30 minutes and a high of 8.74c for 60 minutes/ accidentally left the refrigerator door open too long with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  Concomitant medications included hepatitis B vaccine for Prophylactic vaccination.  On 08-Jun-2023, the patient received a dose of suspect poliomyelitis vaccine (inactivated) (ipv) (vero) Suspension for injection at dose of 0.5 ml (lot number: V1A021M, expiration date: 27-Feb-2024) via intramuscular route in unknown administration site for Immunization (Immunisation) which were exposed to a temperature excursion/low of 1.85c for 30 minutes and a high of 8.74c for 60 minutes/ accidentally left the refrigerator door open too long with no reported adverse event (poor quality product administered) (latency: same day).  No lab data reported.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event ipol were exposed to a temperature excursion/low of 1.85c for 30 minutes and a high of 8.74c for 60 minutes/ accidentally left the refrigerator door open too long/product used:used, with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: MEN
Symptoms: Medication error, No adverse event, Product preparation issue
Clinical narrative: 0.5ml vial of menquadfi reconstituted with 0.5ml sterile water was administered to a patient with no reported adverse event; Initial information was received on 24-Jul-2023 regarding an unsolicited valid non-serious case received from other health professional.  This case involves an unknown age/gender patient who received 0.5ml vial of meningococcal a-c-y-w135 (t conj) vaccine [Menquadfi] reconstituted with 0.5ml sterile water with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On 24-Jul-2023, a dose of suspect meningococcal a-c-y-w135 (t conj) vaccine Solution for injection at dose of 0.5 ml (lot number, strength, expiration date, route, administration site: Unknown) for Immunization (immunisation) reconstituted with 0.5ml sterile water was administered to a patient with no reported adverse event (product preparation issue) (latency: same day). Information on the batch number was requested.  No lab data reported.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event 0.5ml vial of menquadfi reconstituted with 0.5ml sterile water was administered to a patient with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.17
Sex: F
Vaccine: UNK
Symptoms: Medication error, No adverse event, Single component of a two-component product administered
Clinical narrative: 2-month-old has been given half the dose of the blue lid of pentacel, green lid has not been administered with no reported adverse event; Initial information received on 24-Jul-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 2 months old female patient who had been given half the dose of the blue lid of pentacel, green lid has not been administered with no reported adverse event   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(vero)/HIB(PRP/T) vaccine, Suspension for injection via unknown route in unknown administration site for prophylactic vaccination (strength, dose, batch number and expiry date: unknown), 2-month-old had been given half the dose of the blue lid of pentacel, green lid has not been administered with no reported adverse event (Single component of a two-component product administered) (latency same day).  Information on the batch number was requested  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event Single component of a two-component product administered.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Erectile dysfunction, Hypoaesthesia, Limb injury, Memory impairment, Neuropathy peripheral
Clinical narrative: My first adverse reaction was when I went home for a trip to the country in February 2022. I was a the beach and my daughter very lightly hit my the top of my foot with her plastic shovel. I was instantly cut and started to bleed something I thought was strange and cannot remember happening before. Subsequently my short term memory isn't as sharp, I have neuropathy/ numbness/ tingling in mm feet mainly toes, intermittent swelling in feet, erectile dysfunctions issues. I didn't have any of theses problems before I got boosted.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia, Peripheral swelling
Clinical narrative: My first adverse reaction was when I went home for a trip to the country in February 2022. I was a the beach and my daughter very lightly hit my the top of my foot with her plastic shovel. I was instantly cut and started to bleed something I thought was strange and cannot remember happening before. Subsequently my short term memory isn't as sharp, I have neuropathy/ numbness/ tingling in mm feet mainly toes, intermittent swelling in feet, erectile dysfunctions issues. I didn't have any of theses problems before I got boosted.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Autoimmune disorder, Hyperglycaemia, Laboratory test, Type 1 diabetes mellitus
Clinical narrative: 4 months after the second vaccination Patient began to develop hyperglycemia which in July of 2022 resulted in a diagnosis of Type 1 diabetes, which is an autoimmune disorder that hadn't been diagnosed previously
Age: 18.0
Sex: M
Vaccine: HPV9, MENB
Symptoms: Blood test abnormal, Erythema, Immune thrombocytopenia, Petechiae, Platelet count decreased
Clinical narrative: Less than 1 month after vaccine, I went back to pediatrician because i noticed little red dots all over my legs that didnt go away after a week. Doctor informed me the dots were petechiae, and sent me for immediate blood work. Platelet count was 12 (10*3/uL).  I have had ITP since receiving the vaccine, and about a year after the vaccine was diagnosed with LUPUS (SLE), with the ITP being from the SLE. I have tried just about every SLE treatment with no improvement (plaquenil, imuran, methotrexate, cellcept, medrol, prednisone, benlysta, saphnelo)
Age: 18.0
Sex: M
Vaccine: HPV9, MENB
Symptoms: Systemic lupus erythematosus
Clinical narrative: Less than 1 month after vaccine, I went back to pediatrician because i noticed little red dots all over my legs that didnt go away after a week. Doctor informed me the dots were petechiae, and sent me for immediate blood work. Platelet count was 12 (10*3/uL).  I have had ITP since receiving the vaccine, and about a year after the vaccine was diagnosed with LUPUS (SLE), with the ITP being from the SLE. I have tried just about every SLE treatment with no improvement (plaquenil, imuran, methotrexate, cellcept, medrol, prednisone, benlysta, saphnelo)
Age: 43.0
Sex: F
Vaccine: TD
Symptoms: Diarrhoea, Disturbance in attention, Fatigue, Muscular weakness
Clinical narrative: Diarrhea lasting over two weeks, muscle weakness, fatigue, difficulty concentrating
Age: 0.83
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: Patient was due for their second dose of the Moderna Vaccine. Our facility only had the monovalent vaccine and administered to the patient due to their need for the second dose of the covid vaccine.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Pruritus, Pyrexia, Rash
Clinical narrative: Patient experienced a rash, itching, fever, and chills for 24 hours.
Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: Angiogram cerebral, Blood magnesium, Differential white blood cell count, Full blood count, Headache
Clinical narrative: acute onset of daily headache that started on 11/6/23, involved left side of head and face, associated with numbness and tingling in face and head, some tearing of the eye on left. Has persisted. Has seen multiple doctors including primary care and neurologist and has 2nd opinion with another neurologist in near future. Has been tried on multiple medications and remains on medications  (steroids, verapamil, NSAID, Emgality, topiramate)
Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypoaesthesia, Lacrimation increased, Magnetic resonance imaging head, Metabolic function test, Paraesthesia
Clinical narrative: acute onset of daily headache that started on 11/6/23, involved left side of head and face, associated with numbness and tingling in face and head, some tearing of the eye on left. Has persisted. Has seen multiple doctors including primary care and neurologist and has 2nd opinion with another neurologist in near future. Has been tried on multiple medications and remains on medications  (steroids, verapamil, NSAID, Emgality, topiramate)
Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: Red blood cell sedimentation rate
Clinical narrative: acute onset of daily headache that started on 11/6/23, involved left side of head and face, associated with numbness and tingling in face and head, some tearing of the eye on left. Has persisted. Has seen multiple doctors including primary care and neurologist and has 2nd opinion with another neurologist in near future. Has been tried on multiple medications and remains on medications  (steroids, verapamil, NSAID, Emgality, topiramate)
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Acute hepatic failure, Acute kidney injury, Blood creatinine increased, Pancreatic mass, Yellow skin
Clinical narrative: Pt developed symptoms around est 7/22 and pt recievedbooster a month prior. Pt states his skin was yellowing.
Age: 45.0
Sex: F
Vaccine: TDAP
Symptoms: Peripheral swelling, Skin reaction
Clinical narrative: THE NEXT DAY THE PATIENT'S ARM WAS RED AND SWOLLEN
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Swelling
Clinical narrative: redness and swelling
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Injection site haemorrhage, Injection site pain, Syncope
Clinical narrative: Patient received IM Moderna injection in left arm. Deltoid muscle bleed a little, but clotted with a bandage. Patient states site of injection had pain. Pt fainted for around 30 seconds and awoken about a minute later. 911 was called. Pt recovered after an hour of sitting down and left the pharmacy.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Areflexia, CSF cell count normal, CSF protein increased, Dysstasia, Guillain-Barre syndrome
Clinical narrative: Guillain Barre Syndrome (AIDP).  Previously healthy and active 75yo pt developed progressive bilateral leg weakness accompanied by sensory changes over the course of 36hrs beginning 7/25-26.  Hospitalized 7/27 with progressive bilateral leg and arm weakness, absent reflexes, eventually unable to stand.  LP showed increased protein, normal cell count.  IVIG x5d started 7/27.  To date no progression to bulbar, facial or respiratory nerves.  Negative workup for other causes including recent viral infections, tickborne illness, diarrheal illness, medication, or other conditions.  Received COVID vaccination (as noted above) approximately 2wks earlier.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Immunoglobulin therapy, Laboratory test normal, Muscular weakness, Sensory disturbance, Viral test negative
Clinical narrative: Guillain Barre Syndrome (AIDP).  Previously healthy and active 75yo pt developed progressive bilateral leg weakness accompanied by sensory changes over the course of 36hrs beginning 7/25-26.  Hospitalized 7/27 with progressive bilateral leg and arm weakness, absent reflexes, eventually unable to stand.  LP showed increased protein, normal cell count.  IVIG x5d started 7/27.  To date no progression to bulbar, facial or respiratory nerves.  Negative workup for other causes including recent viral infections, tickborne illness, diarrheal illness, medication, or other conditions.  Received COVID vaccination (as noted above) approximately 2wks earlier.
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: Breast cancer female, Herpes zoster, Surgery, Thrombosis
Clinical narrative: Breast cancer on side of vaccine Shingles times 2 on left Blood clots
Age: 80.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Patient developed a shingles-like rash on his upper right arm (injection was in left arm) approximately 3 days after getting his 2nd Shingrix dose.  He reports the rash was not painful and did not itch.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Rash similar to mild chickenpox on front of shins, over upper and lower arms, under breasts, still persistent after a week, starting to subside.
Age: 12.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Cold sweat, Headache, Pallor, Thirst
Clinical narrative: Patient with grandmother to receive vaccines. After administration of vaccines at 9:55am, patient stated having a headache. Nurse noted pale and clammy skin, and vitals were taken at9:56am with BP100/66 , HR 62, 0xygen saturation at 100 %. Patient then stated feeling thirsty  at 9:57am, water was provided and AAOx4.  Vital signs were taken at 10:03am,  BP 106/84, HR 80, oxygen saturation at 100%. Patent was able to continue communicating and verifying name and date of birth . Patient stated , " im starting to feel better now". VS taken at 10:08am with HR at 77, Oxygen saturation at 100 %, BP 104/80 with signs and symptoms of improvement. At 10:15 patient reported not feeling lightheaded, headache had diminished,  and showed no signs of distress. Patient and mother were advised if symptoms were to return , to seek emergency assistance. Both patient and mother verbalized understanding. Patient was able to stand up slowly without assistance and was released from our care.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Back pain, Biopsy lung abnormal, Bone cancer metastatic, Chemotherapy, Computerised tomogram
Clinical narrative: 2 months after patient's 2nd Covid-19 booster shot:  Rib pain, lower back pain -- > metastatic bone cancer, biopsy-confirmed new primary stage IV lung cancer.  Treatment was chemotherapy.   February 5, 2021  Patient received his 1st Moderna vaccine on his R arm. March 5, 2021  He receive his 2nd Moderna vaccine in his L arm. Early May 2021  He felt a pain in his rib. June 2021  The rib pain was still there despite OTC remedies. X-ray imaging was done. It was not easy for him to do the everyday kind of healthy things he used to (preparing his own breakfast, walking in the park, watering his plants)..  July 2021  More imaging and a biopsy was done that confirmed a primary lung cancer with bone metastases among other organ necrosis findings. It was difficult and painful for him to get out and in to bed. August 5, 2021  Patient got admitted a local Medical Center. Eating and moving were both painful.  Mid-August, 2021 - They had discharged him to a rehabilitation center. Early September 2021  Patient got his 1st round of chemotherapy as an outpatient status during the Rehabilitation Admission.  Complications manifesting from abnormal blood cell counts ensued. Mid- September 2021  The local Medical Center re-admitted him to the Intensive Care Unit. September 27, 2021  The local Medical Center discharged him to home health hospice. October 6, 2021  Patient was witnessed in taking his last gasp of breath.  He was pronounced dead by a home health certified nurse early that morning. Patient's health was regularly followed by the local Medical Center and the local Health clinic for decades. He was faithful in following medical guidance and keeping himself healthy. Other than his 2008 history of prostate cancer, other conditions were all minimal and well-controlled or repaired. The July 2021-diagnosed new primary lung cancer developed rapidly as a result of the experimental vaccine. The mRNA vaccine interfered with/confused Dad's natural system to keep himself healthy.  His was one of many precious lives killed, in the name of a lab-created COVID-19 virus, by a "remedy" vaccine tested in acceleration, on the human population, especially the vulnerable, obscuring actionable cause of its adverse effects.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Full blood count abnormal, Gait disturbance, Imaging procedure abnormal, Intensive care
Clinical narrative: 2 months after patient's 2nd Covid-19 booster shot:  Rib pain, lower back pain -- > metastatic bone cancer, biopsy-confirmed new primary stage IV lung cancer.  Treatment was chemotherapy.   February 5, 2021  Patient received his 1st Moderna vaccine on his R arm. March 5, 2021  He receive his 2nd Moderna vaccine in his L arm. Early May 2021  He felt a pain in his rib. June 2021  The rib pain was still there despite OTC remedies. X-ray imaging was done. It was not easy for him to do the everyday kind of healthy things he used to (preparing his own breakfast, walking in the park, watering his plants)..  July 2021  More imaging and a biopsy was done that confirmed a primary lung cancer with bone metastases among other organ necrosis findings. It was difficult and painful for him to get out and in to bed. August 5, 2021  Patient got admitted a local Medical Center. Eating and moving were both painful.  Mid-August, 2021 - They had discharged him to a rehabilitation center. Early September 2021  Patient got his 1st round of chemotherapy as an outpatient status during the Rehabilitation Admission.  Complications manifesting from abnormal blood cell counts ensued. Mid- September 2021  The local Medical Center re-admitted him to the Intensive Care Unit. September 27, 2021  The local Medical Center discharged him to home health hospice. October 6, 2021  Patient was witnessed in taking his last gasp of breath.  He was pronounced dead by a home health certified nurse early that morning. Patient's health was regularly followed by the local Medical Center and the local Health clinic for decades. He was faithful in following medical guidance and keeping himself healthy. Other than his 2008 history of prostate cancer, other conditions were all minimal and well-controlled or repaired. The July 2021-diagnosed new primary lung cancer developed rapidly as a result of the experimental vaccine. The mRNA vaccine interfered with/confused Dad's natural system to keep himself healthy.  His was one of many precious lives killed, in the name of a lab-created COVID-19 virus, by a "remedy" vaccine tested in acceleration, on the human population, especially the vulnerable, obscuring actionable cause of its adverse effects.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Loss of personal independence in daily activities, Lung carcinoma cell type unspecified stage IV, Magnetic resonance imaging, Mobility decreased, Multi-organ disorder
Clinical narrative: 2 months after patient's 2nd Covid-19 booster shot:  Rib pain, lower back pain -- > metastatic bone cancer, biopsy-confirmed new primary stage IV lung cancer.  Treatment was chemotherapy.   February 5, 2021  Patient received his 1st Moderna vaccine on his R arm. March 5, 2021  He receive his 2nd Moderna vaccine in his L arm. Early May 2021  He felt a pain in his rib. June 2021  The rib pain was still there despite OTC remedies. X-ray imaging was done. It was not easy for him to do the everyday kind of healthy things he used to (preparing his own breakfast, walking in the park, watering his plants)..  July 2021  More imaging and a biopsy was done that confirmed a primary lung cancer with bone metastases among other organ necrosis findings. It was difficult and painful for him to get out and in to bed. August 5, 2021  Patient got admitted a local Medical Center. Eating and moving were both painful.  Mid-August, 2021 - They had discharged him to a rehabilitation center. Early September 2021  Patient got his 1st round of chemotherapy as an outpatient status during the Rehabilitation Admission.  Complications manifesting from abnormal blood cell counts ensued. Mid- September 2021  The local Medical Center re-admitted him to the Intensive Care Unit. September 27, 2021  The local Medical Center discharged him to home health hospice. October 6, 2021  Patient was witnessed in taking his last gasp of breath.  He was pronounced dead by a home health certified nurse early that morning. Patient's health was regularly followed by the local Medical Center and the local Health clinic for decades. He was faithful in following medical guidance and keeping himself healthy. Other than his 2008 history of prostate cancer, other conditions were all minimal and well-controlled or repaired. The July 2021-diagnosed new primary lung cancer developed rapidly as a result of the experimental vaccine. The mRNA vaccine interfered with/confused Dad's natural system to keep himself healthy.  His was one of many precious lives killed, in the name of a lab-created COVID-19 virus, by a "remedy" vaccine tested in acceleration, on the human population, especially the vulnerable, obscuring actionable cause of its adverse effects.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Musculoskeletal chest pain, Necrosis, Pain, Positron emission tomogram, Procedural complication
Clinical narrative: 2 months after patient's 2nd Covid-19 booster shot:  Rib pain, lower back pain -- > metastatic bone cancer, biopsy-confirmed new primary stage IV lung cancer.  Treatment was chemotherapy.   February 5, 2021  Patient received his 1st Moderna vaccine on his R arm. March 5, 2021  He receive his 2nd Moderna vaccine in his L arm. Early May 2021  He felt a pain in his rib. June 2021  The rib pain was still there despite OTC remedies. X-ray imaging was done. It was not easy for him to do the everyday kind of healthy things he used to (preparing his own breakfast, walking in the park, watering his plants)..  July 2021  More imaging and a biopsy was done that confirmed a primary lung cancer with bone metastases among other organ necrosis findings. It was difficult and painful for him to get out and in to bed. August 5, 2021  Patient got admitted a local Medical Center. Eating and moving were both painful.  Mid-August, 2021 - They had discharged him to a rehabilitation center. Early September 2021  Patient got his 1st round of chemotherapy as an outpatient status during the Rehabilitation Admission.  Complications manifesting from abnormal blood cell counts ensued. Mid- September 2021  The local Medical Center re-admitted him to the Intensive Care Unit. September 27, 2021  The local Medical Center discharged him to home health hospice. October 6, 2021  Patient was witnessed in taking his last gasp of breath.  He was pronounced dead by a home health certified nurse early that morning. Patient's health was regularly followed by the local Medical Center and the local Health clinic for decades. He was faithful in following medical guidance and keeping himself healthy. Other than his 2008 history of prostate cancer, other conditions were all minimal and well-controlled or repaired. The July 2021-diagnosed new primary lung cancer developed rapidly as a result of the experimental vaccine. The mRNA vaccine interfered with/confused Dad's natural system to keep himself healthy.  His was one of many precious lives killed, in the name of a lab-created COVID-19 virus, by a "remedy" vaccine tested in acceleration, on the human population, especially the vulnerable, obscuring actionable cause of its adverse effects.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Respiratory arrest, X-ray
Clinical narrative: 2 months after patient's 2nd Covid-19 booster shot:  Rib pain, lower back pain -- > metastatic bone cancer, biopsy-confirmed new primary stage IV lung cancer.  Treatment was chemotherapy.   February 5, 2021  Patient received his 1st Moderna vaccine on his R arm. March 5, 2021  He receive his 2nd Moderna vaccine in his L arm. Early May 2021  He felt a pain in his rib. June 2021  The rib pain was still there despite OTC remedies. X-ray imaging was done. It was not easy for him to do the everyday kind of healthy things he used to (preparing his own breakfast, walking in the park, watering his plants)..  July 2021  More imaging and a biopsy was done that confirmed a primary lung cancer with bone metastases among other organ necrosis findings. It was difficult and painful for him to get out and in to bed. August 5, 2021  Patient got admitted a local Medical Center. Eating and moving were both painful.  Mid-August, 2021 - They had discharged him to a rehabilitation center. Early September 2021  Patient got his 1st round of chemotherapy as an outpatient status during the Rehabilitation Admission.  Complications manifesting from abnormal blood cell counts ensued. Mid- September 2021  The local Medical Center re-admitted him to the Intensive Care Unit. September 27, 2021  The local Medical Center discharged him to home health hospice. October 6, 2021  Patient was witnessed in taking his last gasp of breath.  He was pronounced dead by a home health certified nurse early that morning. Patient's health was regularly followed by the local Medical Center and the local Health clinic for decades. He was faithful in following medical guidance and keeping himself healthy. Other than his 2008 history of prostate cancer, other conditions were all minimal and well-controlled or repaired. The July 2021-diagnosed new primary lung cancer developed rapidly as a result of the experimental vaccine. The mRNA vaccine interfered with/confused Dad's natural system to keep himself healthy.  His was one of many precious lives killed, in the name of a lab-created COVID-19 virus, by a "remedy" vaccine tested in acceleration, on the human population, especially the vulnerable, obscuring actionable cause of its adverse effects.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia
Clinical narrative: 2 months after patient's 2nd Covid-19 booster shot: altered sense of taste.  Foods tasted bland.  More salt needed to be added.   PCP was notified.  No treatment offered.  Symptoms still come and go.
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Bell's palsy, Neurological symptom
Clinical narrative: Patient reports having stroke like symptoms the day after the vaccination. He reports that was diagnosed with bell's palsy.
Age: 5.0
Sex: F
Vaccine: IPV
Symptoms: Blood test, Computerised tomogram, Confusional state, Eye movement disorder, Headache
Clinical narrative: Days after getting vaccine she complained of a headache. Next night she threw up twice. Next day after that she had a sudden and extreme eye tic that cause her mental confusion and her eyes to widen and roll to the right side, over and over again. Behavior regression, headaches and tics. This has been 3 weeks of symptoms.
Age: 5.0
Sex: F
Vaccine: IPV
Symptoms: Regressive behaviour, Tic, Vomiting
Clinical narrative: Days after getting vaccine she complained of a headache. Next night she threw up twice. Next day after that she had a sudden and extreme eye tic that cause her mental confusion and her eyes to widen and roll to the right side, over and over again. Behavior regression, headaches and tics. This has been 3 weeks of symptoms.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Brain fog, Fatigue, Fluid retention, Hypersomnia, Migraine
Clinical narrative: Unilateral laterothoracic exanthem, raynauds, purpura, migraines, weight gain, fluid retention, brain fog, personality change, hypersomnia within 2 weeks of vaccination; fatigue, fever, body aches, induration at vaccine site 12-24 hrs after vaccine
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Personality change, Purpura, Pyrexia, Rash
Clinical narrative: Unilateral laterothoracic exanthem, raynauds, purpura, migraines, weight gain, fluid retention, brain fog, personality change, hypersomnia within 2 weeks of vaccination; fatigue, fever, body aches, induration at vaccine site 12-24 hrs after vaccine
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Raynaud's phenomenon, Vaccination site induration, Weight increased
Clinical narrative: Unilateral laterothoracic exanthem, raynauds, purpura, migraines, weight gain, fluid retention, brain fog, personality change, hypersomnia within 2 weeks of vaccination; fatigue, fever, body aches, induration at vaccine site 12-24 hrs after vaccine
Age: 36.0
Sex: F
Vaccine: MENB, VARZOS
Symptoms: No adverse event, Product preparation error
Clinical narrative: Medical assistant mixed the Shingrix with  the wrong dilutent. She mixed the powder form w/ Sterile Diluent, instead of Lyophilized ge antigen. No adverse reaction occurred.
Age: 66.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: No adverse event, Product preparation error
Clinical narrative: Medical assistant mixed Shingrix with  the wrong diluent. She mixed the powder  form w/ sterile diluent, instead of  Lyophilized gE antigen, No adverse  reaction occurred.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Asthenia, Bladder catheterisation, Blood culture negative
Clinical narrative: Patient is a 63 year-old female patient of, MD with history of hypothyroidism, and small fiber neuropathy/myelopathy who presented to Hospital on 7/2/23 with fatigue, weakness, and cough.   Patient was found to be positive for COVID-19 with additional concerns for superimposed bacterial CAP. CTPA showing peribronchiolar airspace opacities in the right upper and lower lobes consistent with bacterial pneumonia so IV ceftriaxone and azithromycin were started. Patient also started on decadron. Patient required oxygen supplementation and was able to wean down to room air prior to discharge. Patient found to have UTI, symptoms improved with antibiotics.   Acute hypoxemic respiratory failure COVID-19 viral pneumonia Suspected community acquired pneumonia Respiratory failure in setting of pneumonia, potentially combination of viral from COVID with bacterial superimposed given imaging findings Imaging: CTPA with peribronchiolar airspace opacities in the right upper and right lower lobes most confluent in the right upper lobe, no PE Medical therapy: IV Rocephin and Azithromycin, decadron. Transition to orals at discharge Urinary antigens negative for strep. pneumo and legionella Continue Mucinex and hycodan for cough Continue claritin for eustachian tube dysfunction Nasal Ocean Spray for congestion Sepsis Febrile and tachycardic on admission with normal lactate, likely due to pneumonia Blood cultures preliminary result showing no growth Continue COVID-19 treatment as above and antibiotics with ceftriaxone/azithromycin   UTI - improved Urinary cultures positive for Klebsiella pneumonia and E. coli, likely 2/2 patient intermittent self catheterization, POA  Patient already on rocephin therefore not starting new abx at this time, will continue to monitor   Hyperglycemia Elevated glucose in the setting of infection and decadron use Improving since starting SSI Continue SSI   Hyperkalemia Elevated potassium in the setting of potential dehydration, less likely medication induced Hold IVF in the setting of COVID infection Monitor K+, consider Lokelma if indicated   Hypothyroidism Continue home levothyroxine   Myelopathy Small fiber neuropathy Follows with neurology, chronically with lower extremity weakness and using walker Continue home pregabalin   Underweight Body mass index is 19.22 kg/m². In the setting of COVID and CAP Encourage PO intake
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood glucose increased, Blood lactic acid normal, Blood potassium increased, COVID-19, COVID-19 pneumonia
Clinical narrative: Patient is a 63 year-old female patient of, MD with history of hypothyroidism, and small fiber neuropathy/myelopathy who presented to Hospital on 7/2/23 with fatigue, weakness, and cough.   Patient was found to be positive for COVID-19 with additional concerns for superimposed bacterial CAP. CTPA showing peribronchiolar airspace opacities in the right upper and lower lobes consistent with bacterial pneumonia so IV ceftriaxone and azithromycin were started. Patient also started on decadron. Patient required oxygen supplementation and was able to wean down to room air prior to discharge. Patient found to have UTI, symptoms improved with antibiotics.   Acute hypoxemic respiratory failure COVID-19 viral pneumonia Suspected community acquired pneumonia Respiratory failure in setting of pneumonia, potentially combination of viral from COVID with bacterial superimposed given imaging findings Imaging: CTPA with peribronchiolar airspace opacities in the right upper and right lower lobes most confluent in the right upper lobe, no PE Medical therapy: IV Rocephin and Azithromycin, decadron. Transition to orals at discharge Urinary antigens negative for strep. pneumo and legionella Continue Mucinex and hycodan for cough Continue claritin for eustachian tube dysfunction Nasal Ocean Spray for congestion Sepsis Febrile and tachycardic on admission with normal lactate, likely due to pneumonia Blood cultures preliminary result showing no growth Continue COVID-19 treatment as above and antibiotics with ceftriaxone/azithromycin   UTI - improved Urinary cultures positive for Klebsiella pneumonia and E. coli, likely 2/2 patient intermittent self catheterization, POA  Patient already on rocephin therefore not starting new abx at this time, will continue to monitor   Hyperglycemia Elevated glucose in the setting of infection and decadron use Improving since starting SSI Continue SSI   Hyperkalemia Elevated potassium in the setting of potential dehydration, less likely medication induced Hold IVF in the setting of COVID infection Monitor K+, consider Lokelma if indicated   Hypothyroidism Continue home levothyroxine   Myelopathy Small fiber neuropathy Follows with neurology, chronically with lower extremity weakness and using walker Continue home pregabalin   Underweight Body mass index is 19.22 kg/m². In the setting of COVID and CAP Encourage PO intake
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Culture urine positive, Escherichia test positive, Eustachian tube dysfunction, Fatigue
Clinical narrative: Patient is a 63 year-old female patient of, MD with history of hypothyroidism, and small fiber neuropathy/myelopathy who presented to Hospital on 7/2/23 with fatigue, weakness, and cough.   Patient was found to be positive for COVID-19 with additional concerns for superimposed bacterial CAP. CTPA showing peribronchiolar airspace opacities in the right upper and lower lobes consistent with bacterial pneumonia so IV ceftriaxone and azithromycin were started. Patient also started on decadron. Patient required oxygen supplementation and was able to wean down to room air prior to discharge. Patient found to have UTI, symptoms improved with antibiotics.   Acute hypoxemic respiratory failure COVID-19 viral pneumonia Suspected community acquired pneumonia Respiratory failure in setting of pneumonia, potentially combination of viral from COVID with bacterial superimposed given imaging findings Imaging: CTPA with peribronchiolar airspace opacities in the right upper and right lower lobes most confluent in the right upper lobe, no PE Medical therapy: IV Rocephin and Azithromycin, decadron. Transition to orals at discharge Urinary antigens negative for strep. pneumo and legionella Continue Mucinex and hycodan for cough Continue claritin for eustachian tube dysfunction Nasal Ocean Spray for congestion Sepsis Febrile and tachycardic on admission with normal lactate, likely due to pneumonia Blood cultures preliminary result showing no growth Continue COVID-19 treatment as above and antibiotics with ceftriaxone/azithromycin   UTI - improved Urinary cultures positive for Klebsiella pneumonia and E. coli, likely 2/2 patient intermittent self catheterization, POA  Patient already on rocephin therefore not starting new abx at this time, will continue to monitor   Hyperglycemia Elevated glucose in the setting of infection and decadron use Improving since starting SSI Continue SSI   Hyperkalemia Elevated potassium in the setting of potential dehydration, less likely medication induced Hold IVF in the setting of COVID infection Monitor K+, consider Lokelma if indicated   Hypothyroidism Continue home levothyroxine   Myelopathy Small fiber neuropathy Follows with neurology, chronically with lower extremity weakness and using walker Continue home pregabalin   Underweight Body mass index is 19.22 kg/m². In the setting of COVID and CAP Encourage PO intake
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hyperglycaemia, Hyperkalaemia, Klebsiella test positive, Legionella test, Lung opacity
Clinical narrative: Patient is a 63 year-old female patient of, MD with history of hypothyroidism, and small fiber neuropathy/myelopathy who presented to Hospital on 7/2/23 with fatigue, weakness, and cough.   Patient was found to be positive for COVID-19 with additional concerns for superimposed bacterial CAP. CTPA showing peribronchiolar airspace opacities in the right upper and lower lobes consistent with bacterial pneumonia so IV ceftriaxone and azithromycin were started. Patient also started on decadron. Patient required oxygen supplementation and was able to wean down to room air prior to discharge. Patient found to have UTI, symptoms improved with antibiotics.   Acute hypoxemic respiratory failure COVID-19 viral pneumonia Suspected community acquired pneumonia Respiratory failure in setting of pneumonia, potentially combination of viral from COVID with bacterial superimposed given imaging findings Imaging: CTPA with peribronchiolar airspace opacities in the right upper and right lower lobes most confluent in the right upper lobe, no PE Medical therapy: IV Rocephin and Azithromycin, decadron. Transition to orals at discharge Urinary antigens negative for strep. pneumo and legionella Continue Mucinex and hycodan for cough Continue claritin for eustachian tube dysfunction Nasal Ocean Spray for congestion Sepsis Febrile and tachycardic on admission with normal lactate, likely due to pneumonia Blood cultures preliminary result showing no growth Continue COVID-19 treatment as above and antibiotics with ceftriaxone/azithromycin   UTI - improved Urinary cultures positive for Klebsiella pneumonia and E. coli, likely 2/2 patient intermittent self catheterization, POA  Patient already on rocephin therefore not starting new abx at this time, will continue to monitor   Hyperglycemia Elevated glucose in the setting of infection and decadron use Improving since starting SSI Continue SSI   Hyperkalemia Elevated potassium in the setting of potential dehydration, less likely medication induced Hold IVF in the setting of COVID infection Monitor K+, consider Lokelma if indicated   Hypothyroidism Continue home levothyroxine   Myelopathy Small fiber neuropathy Follows with neurology, chronically with lower extremity weakness and using walker Continue home pregabalin   Underweight Body mass index is 19.22 kg/m². In the setting of COVID and CAP Encourage PO intake
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pneumonia, Pneumonia bacterial, Pyrexia, Respiratory failure, Respiratory tract congestion
Clinical narrative: Patient is a 63 year-old female patient of, MD with history of hypothyroidism, and small fiber neuropathy/myelopathy who presented to Hospital on 7/2/23 with fatigue, weakness, and cough.   Patient was found to be positive for COVID-19 with additional concerns for superimposed bacterial CAP. CTPA showing peribronchiolar airspace opacities in the right upper and lower lobes consistent with bacterial pneumonia so IV ceftriaxone and azithromycin were started. Patient also started on decadron. Patient required oxygen supplementation and was able to wean down to room air prior to discharge. Patient found to have UTI, symptoms improved with antibiotics.   Acute hypoxemic respiratory failure COVID-19 viral pneumonia Suspected community acquired pneumonia Respiratory failure in setting of pneumonia, potentially combination of viral from COVID with bacterial superimposed given imaging findings Imaging: CTPA with peribronchiolar airspace opacities in the right upper and right lower lobes most confluent in the right upper lobe, no PE Medical therapy: IV Rocephin and Azithromycin, decadron. Transition to orals at discharge Urinary antigens negative for strep. pneumo and legionella Continue Mucinex and hycodan for cough Continue claritin for eustachian tube dysfunction Nasal Ocean Spray for congestion Sepsis Febrile and tachycardic on admission with normal lactate, likely due to pneumonia Blood cultures preliminary result showing no growth Continue COVID-19 treatment as above and antibiotics with ceftriaxone/azithromycin   UTI - improved Urinary cultures positive for Klebsiella pneumonia and E. coli, likely 2/2 patient intermittent self catheterization, POA  Patient already on rocephin therefore not starting new abx at this time, will continue to monitor   Hyperglycemia Elevated glucose in the setting of infection and decadron use Improving since starting SSI Continue SSI   Hyperkalemia Elevated potassium in the setting of potential dehydration, less likely medication induced Hold IVF in the setting of COVID infection Monitor K+, consider Lokelma if indicated   Hypothyroidism Continue home levothyroxine   Myelopathy Small fiber neuropathy Follows with neurology, chronically with lower extremity weakness and using walker Continue home pregabalin   Underweight Body mass index is 19.22 kg/m². In the setting of COVID and CAP Encourage PO intake